Overview
Crohn’s disease is a chronic inflammatory bowel disease (IBD) that can affect any portion of the gastrointestinal tract. It is characterized by periods of flare-ups and remission and may involve abdominal pain, digestive complications, and systemic symptoms.
Researchers are investigating whether certain regenerative medicine approaches, including stem cell–based strategies, may play a role in managing complex inflammatory conditions. Institutions across the United States — including those serving communities in Long Island, New York — continue to study these emerging therapies.
How Stem Cells for Crohn’s Disease Work
Stem cells are being researched for their potential immunomodulatory and regenerative properties. In clinical trials, stem cells may be derived from a patient’s own body (autologous) or from donor sources, depending on study design and regulatory guidelines.
Different research protocols examine various delivery methods and safety measures. Many of these approaches remain investigational and are not widely FDA-approved for Crohn’s disease.
Contact Us
MSC Therapy for Crohn’s
Mesenchymal stem cells (MSCs) are being studied for their potential ability to influence immune signaling and inflammatory pathways. Clinical trials have explored MSC-based approaches in patients with treatment-resistant Crohn’s disease, particularly in complicated cases such as fistulizing disease.
The safety and long-term effectiveness of MSC-based applications continue to be evaluated.
Individuals seeking further information may contact us to discuss whether a consultation with a physician would be appropriate
Contact Us
Source of the Stem Cells for Treating Crohn’s Disease
- Bone – bone marrow has a high concentration of stem cells, so it’s ideal for harvesting in the same manner as doctors do for bone marrow transplants, with small punctures.
- Fat – stem cells are also present in fat, and the procedure to harvest them is similar to liposuction. However, after the fat is removed from the patient, it is processed and spun in a centrifuge to produce a concentrated batch of stem cells for Crohn’s therapy on Long Island, New York.
- Blood – patients will likely need injections of granulocyte colony-stimulating factor to increase the number of stem cells in the blood. Collection takes a couple of hours, and patients may need multiple collection appointments to obtain enough stem cells.
Stem Cell–Based Therapies – FAQs
Are All Stem Cell Therapies for Crohn’s Disease FDA-Approved?
Not all stem cell–based therapies for Crohn’s disease are FDA-approved. Some applications remain investigational and are available only within regulated clinical trials. Individuals in Long Island, NY, researching stem cell science should verify the regulatory status of any specific therapy with licensed healthcare professionals.
Who May Be Considered for Stem Cell–Related Clinical Trials?
Eligibility for stem cell clinical trials depends on factors such as disease severity, prior treatment history, overall health, and specific inclusion criteria established by research institutions. Participation is determined through comprehensive medical evaluation.
What are Some Stem Cell-Based Crohn’s Treatments?
MSCT and AHSCT are two stem cell therapy options for Crohn’s Disease patients. There are also numerous research projects and clinical trials in the works, including expanding MSCT to liminal disease applications.
Can Stem Cells Cure Crohn’s Disease?
Crohn’s disease is currently considered a chronic condition without a known cure. While some clinical studies have investigated whether stem cell–based approaches may help manage severe or treatment-resistant cases, long-term outcomes remain under evaluation, and remission cannot be guarantee
